AGP Picks
View all

California Health Watch
Provided by AGP

California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

Press releases published on August 3, 2026

AIM ImmunoTech Ahead of Schedule on ‘Last Dose’ DURIPANC Critical Clinical Inflection Point
Aug. 3, 2026

AIM ImmunoTech Ahead of Schedule on ‘Last Dose’ DURIPANC Critical Clinical Inflection Point

Indeterminate GlobeNewswire
Corza Medical Expands Gut Suture Portfolio with over 40 New Codes
Aug. 3, 2026

Corza Medical Expands Gut Suture Portfolio with over 40 New Codes

Indeterminate GlobeNewswire
QHSLab (OTCQB:USAQ) Reports Second Quarter and First Half 2026 Unaudited Financial Results
Aug. 3, 2026

QHSLab (OTCQB:USAQ) Reports Second Quarter and First Half 2026 Unaudited Financial Results

Indeterminate GlobeNewswire
Veru to Report Fiscal 2026 Third Quarter Financial Results on August 10th
Aug. 3, 2026

Veru to Report Fiscal 2026 Third Quarter Financial Results on August 10th

Indeterminate GlobeNewswire
Cato Healthcare Supply Releases White Paper Introducing Revenue Preservation Procurement™ for Hospital Supply Chains
Aug. 3, 2026

Cato Healthcare Supply Releases White Paper Introducing Revenue Preservation Procurement™ for Hospital Supply Chains

Indeterminate GlobeNewswire
Cadrenal Therapeutics Solidifies Multi-Indication Strategy for CAD-1005 in Cardiac Acute Critical Care Following Competitor’s Phase 3 Discontinuation
Aug. 3, 2026

Cadrenal Therapeutics Solidifies Multi-Indication Strategy for CAD-1005 in Cardiac Acute Critical Care Following Competitor’s Phase 3 Discontinuation

Indeterminate GlobeNewswire
Cue Biopharma Announces Appointment of James M. Ahlers as Chief Financial Officer and CUE-221 Investigational New Drug Submission
Aug. 3, 2026

Cue Biopharma Announces Appointment of James M. Ahlers as Chief Financial Officer and CUE-221 Investigational New Drug Submission

Indeterminate GlobeNewswire
TOMI Environmental Solutions Receives EPA Registration Expanding SteraMist® for Use in Post-Harvest Agricultural Food Safety Including Cannabis and Hemp Cultivation
Aug. 3, 2026

TOMI Environmental Solutions Receives EPA Registration Expanding SteraMist® for Use in Post-Harvest Agricultural Food Safety Including Cannabis and Hemp Cultivation

Indeterminate GlobeNewswire
Intelligent Bio Solutions Completes Interference Study Examining the Impact of Everyday Substances on Intelligent Fingerprinting System
Aug. 3, 2026

Intelligent Bio Solutions Completes Interference Study Examining the Impact of Everyday Substances on Intelligent Fingerprinting System

Indeterminate GlobeNewswire
Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality
Aug. 3, 2026

Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality

Indeterminate GlobeNewswire
CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion
Aug. 3, 2026

CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion

Indeterminate GlobeNewswire
Candel Therapeutics to Present Extended Data from Phase 3 Results of Aglatimagene Besadenovec at ASTRO 2026
Aug. 3, 2026

Candel Therapeutics to Present Extended Data from Phase 3 Results of Aglatimagene Besadenovec at ASTRO 2026

Indeterminate GlobeNewswire
Canon Medical Systems’ Olea Medical to Expand U.S. Access to eyonis® LCS for AI-Powered Lung Cancer Screening
Aug. 3, 2026

Canon Medical Systems’ Olea Medical to Expand U.S. Access to eyonis® LCS for AI-Powered Lung Cancer Screening

Indeterminate GlobeNewswire
Clearmind Medicine Signs Letter of Intent to Acquire 51% Majority Stake in EV Wireless Charging Solutions for Automated Parking Systems Company
Aug. 3, 2026

Clearmind Medicine Signs Letter of Intent to Acquire 51% Majority Stake in EV Wireless Charging Solutions for Automated Parking Systems Company

Indeterminate GlobeNewswire
CytomX Therapeutics Appoints Alejandra Carvajal as Chief Legal Officer
Aug. 3, 2026

CytomX Therapeutics Appoints Alejandra Carvajal as Chief Legal Officer

Indeterminate GlobeNewswire
Taysha Gene Therapies and Catalent Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Therapy for Rett Syndrome
Aug. 3, 2026

Taysha Gene Therapies and Catalent Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Therapy for Rett Syndrome

Indeterminate GlobeNewswire
Kaléo Announces License Agreement with Amgen for Auto-Injector Technology
Aug. 3, 2026

Kaléo Announces License Agreement with Amgen for Auto-Injector Technology

Indeterminate GlobeNewswire
Mesa Labs Announces First Quarter Financial Results Release Date and Inaugural Earnings Conference Call
Aug. 3, 2026

Mesa Labs Announces First Quarter Financial Results Release Date and Inaugural Earnings Conference Call

Indeterminate GlobeNewswire
Carlsmed Announces Favorable Reimbursement for aprevo® lumbar Procedures
Aug. 3, 2026

Carlsmed Announces Favorable Reimbursement for aprevo® lumbar Procedures

Indeterminate GlobeNewswire
Neuronetics and Jorey Chernett Announce Shared Vision
Aug. 3, 2026

Neuronetics and Jorey Chernett Announce Shared Vision

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

California Health Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.